Total Payments
$12,048
2024 Payments
$686.06
Companies
51
Transactions
612
Medicare Patients
2,808
Medicare Billing
$279,244
Payment Breakdown by Category
Food & Beverage$10,281 (85.3%)
Consulting$1,200 (10.0%)
Other$500.00 (4.2%)
Travel$40.00 (0.3%)
Education$26.75 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,281 | 605 | 85.3% |
| Consulting Fee | $1,200 | 1 | 10.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 4.2% |
| Travel and Lodging | $40.00 | 1 | 0.3% |
| Education | $26.75 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,555 | 99 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,410 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,007 | 58 | $0 (2024) |
| ABBVIE INC. | $989.58 | 60 | $0 (2024) |
| Lilly USA, LLC | $620.53 | 44 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $620.43 | 32 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $605.64 | 35 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $553.81 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $448.18 | 21 | $0 (2023) |
| Allergan, Inc. | $442.79 | 21 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $686.06 | 38 | Novo Nordisk Inc ($138.20) |
| 2023 | $820.17 | 52 | AbbVie Inc. ($166.28) |
| 2022 | $1,702 | 84 | ABBVIE INC. ($405.19) |
| 2021 | $3,326 | 100 | Biohaven Pharmaceuticals, Inc. ($1,377) |
| 2020 | $1,717 | 108 | Novo Nordisk Inc ($345.33) |
| 2019 | $1,311 | 78 | Novo Nordisk Inc ($206.66) |
| 2018 | $1,224 | 63 | Allergan Inc. ($221.03) |
| 2017 | $1,262 | 89 | Novo Nordisk Inc ($234.56) |
All Payment Transactions
612 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: VACCINE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Biological | ||||||
| 07/30/2024 | Noven Pharmaceuticals, Inc. | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ADHD | ||||||
| 07/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Gastroenterology | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: PSYCHIATRY | ||||||
| 05/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Neuroscience | ||||||
| 05/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Gastroenterology | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: VACCINES | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 633 | 1,146 | $244,868 | $77,804 |
| 2022 | 14 | 843 | 1,384 | $262,629 | $88,316 |
| 2021 | 13 | 852 | 1,278 | $201,618 | $68,009 |
| 2020 | 8 | 480 | 884 | $159,685 | $45,115 |
Total Patients
2,808
Total Services
4,692
Medicare Billing
$279,244
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 451 | $121,770 | $36,506 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 251 | $45,933 | $16,302 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $40,356 | $15,365 | 38.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $6,944 | $2,336 | 33.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 52 | $8,216 | $1,953 | 23.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 44 | $8,448 | $1,718 | 20.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 25 | 30 | $3,300 | $1,294 | 39.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 22 | $2,420 | $956.97 | 39.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 14 | 20 | $4,400 | $894.67 | 20.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 26 | $1,976 | $290.68 | 14.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 29 | 45 | $405.00 | $99.00 | 24.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $638.00 | $81.69 | 12.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 62 | $62.00 | $6.07 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 233 | 488 | $131,760 | $42,161 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 163 | 163 | $55,746 | $21,259 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 261 | $47,763 | $17,484 | 36.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 49 | $5,390 | $1,642 | 30.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 34 | 36 | $3,960 | $1,565 | 39.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 24 | 33 | $4,224 | $1,156 | 27.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 37 | 43 | $2,150 | $1,004 | 46.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 59 | $4,484 | $635.11 | 14.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 47 | $1,880 | $454.77 | 24.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 12 | 12 | $2,640 | $365.08 | 13.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 20 | $1,160 | $231.11 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 53 | 84 | $756.00 | $186.35 | 24.6% |
About Dr. William Adcox, MD
Dr. William Adcox, MD is a Family Medicine healthcare provider based in Fayetteville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124086350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Adcox, MD has received a total of $12,048 in payments from pharmaceutical and medical device companies, with $686.06 received in 2024. These payments were reported across 612 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($10,281).
As a Medicare-enrolled provider, Adcox has provided services to 2,808 Medicare beneficiaries, totaling 4,692 services with total Medicare billing of $279,244. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Fayetteville, GA
- Active Since 05/04/2006
- Last Updated 12/20/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124086350
Products in Payments
- NURTEC ODT (Drug) $1,518
- FARXIGA (Drug) $826.08
- Ozempic (Drug) $780.15
- REXULTI (Drug) $740.54
- VRAYLAR (Drug) $629.53
- TRULICITY (Drug) $464.68
- UBRELVY (Drug) $448.88
- JARDIANCE (Drug) $443.84
- Natesto (Drug) $284.20
- XIFAXAN (Drug) $236.04
- JANUVIA (Drug) $217.06
- Saxenda (Drug) $214.56
- MYRBETRIQ (Drug) $213.41
- Aimovig (Biological) $192.98
- SOLIQUA 100/33 (Biological) $183.96
- Victoza (Drug) $171.52
- TOUJEO (Drug) $166.31
- BYSTOLIC (Drug) $138.61
- NAFTIN (Drug) $132.38
- OMNI(R) SURGICAL SYSTEM (US) (Device) $124.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fayetteville
Dr. Daniel Uba, Md/Internal Medicine, MD/INTERNAL MEDICINE
Family Medicine — Payments: $127,961
Family Medicine $127,961
John Ray, M.d, M.D
Family Medicine — Payments: $18,165
Family Medicine $18,165
William Hughes, M.d, M.D
Family Medicine — Payments: $12,858
Family Medicine $12,858
Mark Bonner, Md, MD
Family Medicine — Payments: $12,578
Family Medicine $12,578
Richard Cline, D.o, D.O
Family Medicine — Payments: $12,163
Family Medicine $12,163
Dr. Mark Miller, M.d, M.D
Family Medicine — Payments: $11,078
Family Medicine $11,078